Amanda I Phipps1, John Baron, Polly A Newcomb. 1. Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. aphipps@fhcrc.org
Abstract
BACKGROUND: Smoking and alcohol consumption are associated with an increased risk of developing colorectal cancer. However, it is unclear whether these exposures are associated with survival after colorectal cancer diagnosis. METHODS: Men and women diagnosed with incident colorectal cancer between 1998 and 2007 in 13 counties in western Washington State were identified by using the Surveillance, Epidemiology, and End Results cancer registry. Information on smoking history and alcohol consumption was collected by telephone interview. Follow-up for mortality was completed through linkage to the National Death Index. Cox proportional hazards regression was used to estimate hazard ratios (HR) and 95% confidence intervals (CI) for associations among smoking, alcohol consumption, and mortality after colorectal cancer diagnosis. Stratified analyses were conducted by sex, age at diagnosis (<50 years, ≥ 50 years), tumor site (proximal, distal, rectal), stage (I-II, III-IV), and microsatellite instability status (stable/low, high). RESULTS: Disease-specific and all-cause mortality were significantly higher for smokers (HR, 1.30; 95% CI, 1.09-1.74) compared with never-smokers (HR, 1.51; 95% CI, 1.24-1.83). However, this association was most prominent in those with tumors exhibiting high microsatellite instability (HR, 3.83; 95% CI, 1.32-11.11) and did not extend to those with rectal cancer (HR, 1.08; 95% CI, 0.72-1.61) or those diagnosed before age 50 years (HR, 0.99; 95% CI, 0.67-1.48). Alcohol consumption was not associated with disease-specific or all-cause mortality, regardless of patient or tumor characteristics. CONCLUSIONS: In addition to an association with disease risk, smoking is associated with increased mortality after colorectal cancer diagnosis. This association is especially pronounced for colorectal cancer with high microsatellite instability.
BACKGROUND: Smoking and alcohol consumption are associated with an increased risk of developing colorectal cancer. However, it is unclear whether these exposures are associated with survival after colorectal cancer diagnosis. METHODS:Men and women diagnosed with incident colorectal cancer between 1998 and 2007 in 13 counties in western Washington State were identified by using the Surveillance, Epidemiology, and End Results cancer registry. Information on smoking history and alcohol consumption was collected by telephone interview. Follow-up for mortality was completed through linkage to the National Death Index. Cox proportional hazards regression was used to estimate hazard ratios (HR) and 95% confidence intervals (CI) for associations among smoking, alcohol consumption, and mortality after colorectal cancer diagnosis. Stratified analyses were conducted by sex, age at diagnosis (<50 years, ≥ 50 years), tumor site (proximal, distal, rectal), stage (I-II, III-IV), and microsatellite instability status (stable/low, high). RESULTS: Disease-specific and all-cause mortality were significantly higher for smokers (HR, 1.30; 95% CI, 1.09-1.74) compared with never-smokers (HR, 1.51; 95% CI, 1.24-1.83). However, this association was most prominent in those with tumors exhibiting high microsatellite instability (HR, 3.83; 95% CI, 1.32-11.11) and did not extend to those with rectal cancer (HR, 1.08; 95% CI, 0.72-1.61) or those diagnosed before age 50 years (HR, 0.99; 95% CI, 0.67-1.48). Alcohol consumption was not associated with disease-specific or all-cause mortality, regardless of patient or tumor characteristics. CONCLUSIONS: In addition to an association with disease risk, smoking is associated with increased mortality after colorectal cancer diagnosis. This association is especially pronounced for colorectal cancer with high microsatellite instability.
Authors: Noralane M Lindor; Lawrence J Burgart; Olga Leontovich; Richard M Goldberg; Julie M Cunningham; Daniel J Sargent; Catherine Walsh-Vockley; Gloria M Petersen; Michael D Walsh; Barbara A Leggett; Joanne P Young; Melissa A Barker; Jeremy R Jass; John Hopper; Steve Gallinger; Bharati Bapat; Mark Redston; Stephen N Thibodeau Journal: J Clin Oncol Date: 2002-02-15 Impact factor: 44.544
Authors: P Yang; J M Cunningham; K C Halling; T G Lesnick; L J Burgart; E M Wiegert; E R Christensen; N M Lindor; J A Katzmann; S N Thibodeau Journal: Mol Genet Metab Date: 2000-12 Impact factor: 4.797
Authors: M Grønbaek; U Becker; D Johansen; A Gottschau; P Schnohr; H O Hein; G Jensen; T I Sørensen Journal: Ann Intern Med Date: 2000-09-19 Impact factor: 25.391
Authors: M L Slattery; K Curtin; K Anderson; K N Ma; L Ballard; S Edwards; D Schaffer; J Potter; M Leppert; W S Samowitz Journal: J Natl Cancer Inst Date: 2000-11-15 Impact factor: 13.506
Authors: C R Boland; S N Thibodeau; S R Hamilton; D Sidransky; J R Eshleman; R W Burt; S J Meltzer; M A Rodriguez-Bigas; R Fodde; G N Ranzani; S Srivastava Journal: Cancer Res Date: 1998-11-15 Impact factor: 12.701
Authors: Joseph C Anderson; Koorosh Moezardalan; Catherine R Messina; Michael Latreille; Robert D Shaw Journal: Dig Dis Sci Date: 2011-07-13 Impact factor: 3.199
Authors: Sheetal Hardikar; Polly A Newcomb; Peter T Campbell; Aung Ko Win; Noralane M Lindor; Daniel D Buchanan; Karen W Makar; Mark A Jenkins; John D Potter; Amanda I Phipps Journal: Cancer Epidemiol Biomarkers Prev Date: 2015-05-14 Impact factor: 4.254
Authors: Jonathan M Kocarnik; Xinwei Hua; Sheetal Hardikar; Jamaica Robinson; Noralane M Lindor; Aung Ko Win; John L Hopper; Jane C Figueiredo; John D Potter; Peter T Campbell; Steven Gallinger; Michelle Cotterchio; Scott V Adams; Stacey A Cohen; Amanda I Phipps; Polly A Newcomb Journal: Cancer Date: 2017-08-25 Impact factor: 6.860
Authors: Robert V Cooney; Weiwen Chai; Adrian A Franke; Lynne R Wilkens; Laurence N Kolonel; Loïc Le Marchand Journal: Cancer Epidemiol Biomarkers Prev Date: 2013-05-15 Impact factor: 4.254
Authors: Amanda I Phipps; Qian Shi; Paul J Limburg; Garth D Nelson; Daniel J Sargent; Frank A Sinicrope; Emily Chan; Sharlene Gill; Richard M Goldberg; Morton Kahlenberg; Suresh Nair; Anthony F Shields; Polly A Newcomb; Steven R Alberts Journal: Int J Cancer Date: 2016-05-09 Impact factor: 7.396